The therapy of functional dyspepsia: an update.

Med Pharm Rep

Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca, Cluj County Clinical Emergency Hospital, Romania.

Published: November 2021

Functional dyspepsia (FD) is a common disorder of the gut-brain interaction (previously named functional gastrointestinal disorders). Recent data evaluate its prevalence to 7% worldwide. FD is classified into epigastric pain syndrome (EPS) and PDS (PDS). While the diagnosis of FD is standardized thanks to the work of the Rome Foundation committees, the therapy is far from being satisfactory. A recent European guide found few strong recommendations, reflecting the lack of sufficient data for high levels of evidence. This review is presenting possibilities of management of FD. Therapeutic indications should target the main symptoms and be proportionate to the severity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11188028PMC
http://dx.doi.org/10.15386/mpr-2509DOI Listing

Publication Analysis

Top Keywords

functional dyspepsia
8
therapy functional
4
dyspepsia update
4
update functional
4
dyspepsia common
4
common disorder
4
disorder gut-brain
4
gut-brain interaction
4
interaction named
4
named functional
4

Similar Publications

Efficacy of vagus nerve stimulation in gastrointestinal disorders: a systematic review.

Gastroenterol Rep (Oxf)

January 2025

Department of Gastroenterology-Hepatology, NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.

Dysfunction of the vagus nerve has been suggested as a contributing factor in various gastrointestinal disorders, prompting interest in vagus nerve stimulation (VNS) as a non-pharmacological therapy. We performed a systematic review to determine the efficacy of invasive and non-invasive VNS in gastrointestinal disorders, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), functional dyspepsia (FD), functional constipation, gastroesophageal reflux disease, and gastroparesis. We applied a systematic search of the literature in the PubMed, Embase, Web of Science, and Cochrane Library databases in order to identify studies comparing VNS with an adequate control condition (sham stimulation) in patients with gastrointestinal disorders.

View Article and Find Full Text PDF

: Yeokwisan (YWS) is a standardised herbal formula for relieving functional dyspepsia symptoms. : We explored the therapeutic value of YWS and its potential effects on gastritis. Its inhibitory effect on gastric mucosal damage and anti-inflammatory activity in animal models of alcohol- and restraint stress-induced gastritis were also examined.

View Article and Find Full Text PDF

Purpose: The incidence of Functional Dyspepsia (FD) is gradually increasing, yet there are currently no effective treatment methods available. This study explored the effective components, potential targets, and pathways of Shi-San-Wei-He-Zhong-Wan (SSWHZW) in the treatment of FD, aiming to provide new insights into its treatment.

Methods: First, the Chinese Medicine System Pharmacology Database and Analysis Platform (TCMSP) and GeneCards databases were utilized to identify the major active components of SSWHZW and potential therapeutic targets of FD.

View Article and Find Full Text PDF

Background: According to Rome IV, reflux hypersensitivity (RH) represents a novel form of functional esophageal disorder. This study was designed to compare the clinical features of three types of endoscopic-negative heartburn: RH, nonerosive reflux disease (NERD), and functional heartburn (FH).

Methods: Patients with heartburn in a medical center from 01/01/2017 to 10/31/2021 were included.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!